Anzatax

Anzatax Contraindications

paclitaxel

Manufacturer:

Hospira

Distributor:

Zuellig Pharma

Marketer:

Pfizer
Full Prescribing Info
Contraindications
Anzatax Injection Concentrate must not be used in patients who have exhibited hypersensitivity reactions to paclitaxel.
Anzatax Injection Concentrate must not be used in patients who have a history of hypersensitivity reactions to PEG 35 castor oil or drugs formulated in PEG 35 castor oil (e.g., cyclosporin for injection concentrate and teniposide for injection concentrate).
Anzatax Injection Concentrate should not be administered in patients with solid tumours who have a baseline neutrophil counts of <1.5 x 109 cells/L.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in